Valeant Pharmaceuticals Intl Inc. Is at the Mercy of its Lenders

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is trying to get its debt covenants relaxed. Penn West Petroleum Ltd. (TSX:PWT)(NYSE:PWE) has shown that this can be painful.

| More on:
The Motley Fool

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is in danger of defaulting on its debt, which would be yet another catastrophe for shareholders. To save itself from that fate, it is currently negotiating with its lenders to ease covenants.

But this has consequences too, as has been demonstrated by a number of oil companies. Penn West Petroleum Ltd. (TSX:PWT)(NYSE:PWE) is one example. We’ll take a closer look below.

Valeant’s covenants

According to Valeant’s credit agreement, a default will occur if Valeant doesn’t file its 10-K (which includes audited financial statements) by the end of this month. In that scenario, Valeant will then have 30 days to cure the default by filing its 10-K.

Meanwhile, Valeant has already breached the reporting covenant in its bond indentures, which required a 10-K by March 16. As a result, the company is restricted from borrowing any more money from its revolver.

These aren’t the only covenants Valeant must adhere to; there are also certain financial targets that the company must maintain. The company said it expects to be in compliance with all covenants this year and next, but until the company releases audited financials, it’s impossible to know for sure.

Penn West’s experience

At the beginning of last year Penn West was about to breach its debt covenants, which would have meant a default. To avoid such a fate, the company got lenders to relax covenants. And even though an agreement was reached, it was not a fun process.

For starters, Penn West had to lower its quarterly dividend from $0.03 to $0.01. The company also had to cancel a $500 million tranche in its bank facility. It also had to grant floating charge security over all its property. If that wasn’t bad enough, Penn West had to pledge that any asset sales would go towards reducing debt. To top it all off, the company had to agree to higher interest payments.

Anything can happen

This situation with Valeant is a little different, because Valeant hasn’t even released audited financials, making the outcome very unpredictable. Otherwise, Penn West’s experience provides a useful learning experience.

And anonymous sources have already told Reuters that “creditors prepare to slam company with tougher demands” in exchange for relaxing covenants. So one way or another, Valeant is in for a rough ride. This story is far from over.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Benjamin Sinclair has no position in any stocks mentioned.  Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

farmer holds box of leafy greens
Metals and Mining Stocks

Nutrien: Buy, Sell, or Hold in 2025?

Nutrien (TSX:NTR) stock could be a bargain going into the second quarter.

Read more »

Canada national flag waving in wind on clear day
Dividend Stocks

3 of the Best Canadian Stocks Investors Can Buy Right Now

Balancing risk and reward, here are some of the best Canadian stocks to invest in right now!

Read more »

Start line on the highway
Investing

3 Brilliant TSX Stocks to Buy Now and Hold for the Long Term

Don’t let the market’s recent volatility keep you from investing today.

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Monday, March 24

With a strong 1.7% gain, the TSX Composite Index just posted its best weekly performance since November 2024.

Read more »

golden sunset in crude oil refinery with pipeline system
Investing

Is Enbridge Stock a Buy for its 6% Dividend Yield?

Enbridge is up 30% in the past 12 months. Are more gains on the way?

Read more »

woman analyze data
Dividend Stocks

Secure Dividends: How to Turn $10,000 Into Reliable Passive Income

Earn a secure dividend income of over $150 every quarter by investing in these reliable Canadian dividend stocks.

Read more »

Piggy bank with word TFSA for tax-free savings accounts.
Energy Stocks

The Best Canadian Stocks to Buy and Hold Forever in a TFSA

Canadian stocks such as GFL Environmental and Total Energy Services are poised to grow earnings at a steady pace through…

Read more »

A plant grows from coins.
Investing

The Ultimate Growth Stock to Buy With $1,000 Right Now

Alimentation Couche-Tard (TSX:ATD) looks like a great buy for new investors right here.

Read more »